Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

United Therapeutics buy JPMorgan Chase & Co.

Start price
€255.10
21.05.24 / 50%
Target price
€276.33
21.05.25
Performance (%)
-0.08%
Price
€254.90
15:49
Summary
This prediction is currently active. Since the start of the prediction for United Therapeutics the price has only changed by -0.08%. This prediction currently runs until 21.05.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w
United Therapeutics 0.955%
iShares Core DAX® -0.552%
iShares Nasdaq 100 -1.415%
iShares Nikkei 225® -0.877%
iShares S&P 500 -0.415%

Comments by JPMorgan_Chase___Co_ for this prediction

In the thread United Therapeutics diskutieren
Prediction Buy
Perf. (%) -0.08%
Target price 276.330
Change
Ends at 21.05.25

United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at JPMorgan Chase & Co. from $280.00 to $300.00. They now have an "overweight" rating on the stock.
Ratings data for UTHR provided by MarketBeat